Feng Z Li from Quincy, MA, age 75

Professional Records

License Records

Feng Jiano Li

License #:

1201113774

Category:

Cosmetologist License

Feng Li

License #:

0225194595 - Expired

Category:

Real Estate Individual

Issued Date:

Nov 19, 2009

Expiration Date:

Nov 30, 2013

Type:

Salesperson License

Feng Li

License #:

014056

Category:

Clinical Laboratory Technologist

Issued Date:

Nov 5, 2008

Type:

CLINICAL LABORATORY TECHNOLOGIST

Medicine Doctors

Feng Li

View page

Specialties:

Forensic Pathology

Work:

Forensic Medical Management Services PLC
850 Rs Gass Blvd, Nashville, TN 37216
(615) 743-1800 (phone), (615) 743-1890 (fax)

Education:

Medical School
Zhejiang Med Univ, Hangzhou, Zhejiang, China
Graduated: 1983

Languages:

English

Description:

Dr. Li graduated from the Zhejiang Med Univ, Hangzhou, Zhejiang, China in 1983. He works in Nashville, TN and specializes in Forensic Pathology.

Feng Li

View page

Specialties:

Gastroenterology

Education:

Medical School
Tufts University School of Medicine
Graduated: 2002

Description:

Dr. Li graduated from the Tufts University School of Medicine in 2002. He works in Tyler, TX and specializes in Gastroenterology. Dr. Li is affiliated with Mother Francis Hospital.

Feng Li, Tyler TX

View page

Specialties:

Internal Medicine
Gastroenterology
Nephrology

Work:

Trinity Clinic - Gastroenterology
910 E Houston St, Tyler, TX 75702
Univ. Of Md Medical Group
22 S Greene St, Baltimore, MD 21263
Univ. Of Md Medical Group
419 W Redwood St, Baltimore, MD 21201

Education:

Tufts University (2002)

Resumes

Feng Li San Diego, CA

View page

Work:

Qualcomm

Jun 2013 to 2000
Senior Algorithm Engineer
Mitsubishi Electric Research Labs
Cambridge, MA
Nov 2011 to Jun 2013
Adjunct Member Research Scientist
University of Delaware
Newark, DE
Aug 2006 to Oct 2011
Research Assistant
Mitsubishi Electric Research Labs
Cambridge, MA
Jun 2011 to Aug 2011
Research Intern
Thomson Corporate Research
Princeton, NJ
Feb 2009 to May 2009
Research Intern, Technicolor
Microsoft Research Asia

Jul 2008 to Oct 2008
Research Intern
Pacific Research & Development Ltd

Apr 2006 to Jul 2006
Technical Marketing Engineer, Intel Asia
Intel China Software Center

Sep 2005 to Mar 2006
Software Engineering Intern

Education:

University of Delaware
Newark, DE
Sep 2011
Ph.D. in Computer Science
Shanghai Jiao Tong University
Mar 2006
M.E
Fuzhou University
Jul 2003
B.E. in Electrical Engineering

Feng Li West Hollywood, CA

View page

Work:

Apple, Inc
Bethesda, MD
Dec 2010 to Apr 2013
Genius Technician
Microsoft/ Volt Management Corp
Baltimore, MD
Feb 2010 to Dec 2010
Microsoft Student Partner - Marketing
RSM McGladrey/ Tax Firm
Bethesda, MD
Sep 2006 to Jan 2007
File Room Clerk
The Gambian Embassy
Washington, DC
Sep 2005 to Dec 2005
International Politics Intern
Luxenberg, Johnson, & Dickens, P.C
Washington, DC
Jun 2003 to Sep 2003
Summer Law Intern

Education:

University of Maryland
Baltimore, MD
Sep 2004 to May 2010
B.A. in English Literature & Political Science

Skills:

Computer Software: Apple OS X - iWork, iLife, Final Cut Pro; Microsoft Office Suite - Word, Excel, PowerPoint, Access; Internet Browsers - Bing, Internet Explorer, Mozilla Firefox, Google Chrome; Adobe Suite - Lightroom and Photoshop

Feng Li

View page

Business Records

Name / Title

Company / Classification

Phones & Addresses

Feng Li
President

New York Super Buffet Inc
Eating Place

237 Quincy Ave, Quincy, MA 02169
(617) 773-9838

Feng Li
Manager

FENG SHUI REALTY, LC

219 Ml St, Newtonville, MA 02460
Newtonville, MA 02460

Feng Li

ZS INTERNATIONAL BUSINESS CORPORATION

Feng Wu Li

LL YONG JI, INC

Feng Wu Li

F.K. SHERIDAN, LLC

Feng Wu Li

F.K. LIVINGSTON, LLC

Feng Li
President

JIBAO USA, CO., LTD

245 Newbury St, Boston, MA 02116
356 Princeton St, Boston, MA 02128

Feng Shi Li
Treasurer

SHU FENG INTERNATIONAL LIMITED, CORP

65 Harrison Ave, Boston, MA 02111
16 Earl St, Boston, MA 02127

Publications

Us Patents

Azaindole Derivatives As Kinase Inhibitors

View page

US Patent:

20110294806, Dec 1, 2011

Filed:

Dec 11, 2009

Appl. No.:

12/998873

Inventors:

Jiwei Qi - West Roxbury MA, US
Yihan Wang - Newton MA, US
Feng Li - Winchester MA, US
William C. Shakespeare - Southborough MA, US
Anna Kohlmann - Winchster MA, US
David C. Dalgarno - Brookline MA, US
Xiaotian Zhu - Newton MA, US

Assignee:

ARIAD Pharmaceuticals, Inc. - Cambridge MA

International Classification:

A61K 31/437
A61P 35/00
A61K 31/506
C07D 471/04
A61K 31/5377

US Classification:

5142345, 546113, 544127, 544333, 514300, 514256

Abstract:

This invention relates to compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

Phosphorus Derivatives As Kinase Inhibitors

View page

US Patent:

20120202776, Aug 9, 2012

Filed:

May 21, 2009

Appl. No.:

12/736910

Inventors:

Yihan Wang - Newton MA, US
Wei-Sheng Huang - Acton MA, US
Shuangying Liu - Wellesley MA, US
William C. Shakespeare - Southborough MA, US
R. Mathew Thomas - Sharon MA, US
Jiwei Qi - West Roxbury MA, US
Feng Li - Winchester MA, US
Xiaotian Zhu - Newton MA, US
Anna Kohlmann - Winchester MA, US
David C. Dalgarno - Brookline MA, US
Jan Antoinette C. Romero - Somerville MA, US
Dong Zou - Concord MA, US

Assignee:

ARIAD Pharmaceuticals, Inc. - Cambridge MA

International Classification:

A61K 31/675
C07F 9/6512
C07F 9/6561
A61P 35/00
C07F 9/6509
C07F 9/6521
C07F 9/58
C07F 9/6558
C07F 9/6584

US Classification:

514 81, 544243, 544122, 544244, 544232, 544195, 544113, 514 86, 514 80, 514 85, 546 22, 514 89, 514 84, 514 90

Abstract:

The invention features compounds of the general formula (I) in which the variable groups are as defined herein, and to their preparation and use.

Phosphorus Derivatives As Kinase Inhibitors

View page

US Patent:

20130225527, Aug 29, 2013

Filed:

Mar 15, 2013

Appl. No.:

13/843171

Inventors:

ARIAD PHARMACEUTICALS, INC. - , US
Wei-Sheng Huang - Acton MA, US
Shuangying Liu - Wellesley MA, US
William C. Shakespeare - Southborough MA, US
R. Mathew Thomas - Sharon MA, US
Jiwei Qi - West Roxbury MA, US
Feng Li - Winchester MA, US
Xiaotian Zhu - Newton MA, US
Anna Kohlmann - Winchester MA, US
David C. Dalgarno - Brookline MA, US
Jan Antoinette C. Romero - Somerville MA, US
Dong Zou - Concord MA, US

Assignee:

ARIAD PHARMACEUTICALS, INC. - Cambridge MA

International Classification:

C07F 9/6584
C07F 9/6521
C07F 9/58
C07F 9/6558
C07F 9/6561

US Classification:

514 81, 544243, 514 86, 435184, 544122, 544244, 544232, 514 85, 546 22, 514 89, 544195, 514 84, 544182

Abstract:

The invention features compounds of the general formula:in which the variable groups are as defined herein, and to their preparation and use.

Phosphorus Derivatives As Kinase Inhibitors

View page

US Patent:

20130225528, Aug 29, 2013

Filed:

Mar 15, 2013

Appl. No.:

13/843055

Inventors:

ARIAD Pharmaceuticals, Inc. - , US
Wei-Sheng Huang - Acton MA, US
Shuangying Liu - Wellesley MA, US
William C. Shakespeare - Southborough MA, US
R. Mathew Thomas - Sharon MA, US
Jiwei Qi - West Roxbury MA, US
Feng Li - Winchester MA, US
Xiaotian Zhu - Newton MA, US
Anna Kohlmann - Winchester MA, US
David C. Dalgarno - Brookline MA, US
Jan Antoinette C. Romero - Somerville MA, US
Dong Zou - Concord MA, US

Assignee:

ARIAD PHARMACEUTICALS, INC. - Cambridge MA

International Classification:

C07F 9/6512
C07F 9/6584

US Classification:

514 83, 435375, 514 85, 514 86, 514 89, 544122, 544182, 544214, 544232, 544243, 544244, 546 22

Abstract:

The invention features compounds of the general formula:in which the variable groups are as defined herein, and to their preparation and use.

Phosphorus Derivatives As Kinase Inhibitors

View page

US Patent:

20140066406, Mar 6, 2014

Filed:

Mar 15, 2013

Appl. No.:

13/842951

Inventors:

Assignee:

ARIAD PHARMACEUTICALS, INC. - Cambridge MA

International Classification:

C07F 9/6558
C07F 9/6509
C07F 9/6584
C07F 9/6512
C07F 9/6561

US Classification:

514 84, 544243, 514 86, 544122, 544244, 514 81, 544232, 514 85, 544195, 544113, 544182

Abstract:

The invention features compounds of the general formula:in which the variable groups are as defined herein, and to their preparation and use.

Kits And Methods For Temperature Maintenance And Shipment Integrity Of Cell Cultures During Transportation

View page

US Patent:

20220380716, Dec 1, 2022

Filed:

Sep 11, 2020

Appl. No.:

17/642027

Inventors:

- CORNING NY, US
Kirsten Lee Cooper - Waltham MA, US
Feng Li - Shrewsbury MA, US
Sweta Nimesh Parikh - Salem NH, US
Rongjun Zuo - West Roxbury MA, US

International Classification:

C12M 1/00
C12M 1/32
C12M 1/12
B65D 81/18
B65D 81/38
B65D 81/02

Abstract:

A kit for temperature maintenance and shipment integrity of a cell culture is provided, including a well plate, a cell culture, culture media, an insulated receptacle, and a temperature maintenance element. The kit may include a heat release element. The well plate includes a plurality of wells. The cell culture is arranged within each of the plurality of wells of the well plate. Culture media is arranged within each of the plurality of wells of the well plate, where the culture media encapsulates the cell culture. The well plate is arranged within the insulated receptacle. The temperature maintenance element is arranged within the insulated receptacle. The heat release element is also arranged within the insulated receptacle.

Heteroaryl Compounds For Kinase Inhibition

View page

US Patent:

20230102829, Mar 30, 2023

Filed:

Aug 31, 2021

Appl. No.:

17/463457

Inventors:

- OSAKA, JP
YONGJIN GONG - BELMONT MA, US
FENG LI - WINCHESTER MA, US
NICHOLAS E. BENCIVENGA - MALDEN MA, US
DAVID C. DALGARNO - BROOKLINE MA, US
ANNA KOHLMANN - WINCHESTER MA, US
WILLIAM C. SHAKESPEARE - SOUTHBOROUGH MA, US
RANNY M. THOMAS - SHARON MA, US
XIAOTIAN ZHU - NEWTON MA, US
ANGELA V. WEST - FRANKLIN MA, US
WILLMEN YOUNGSAYE - BOSTON MA, US
YUN ZHANG - ACTON MA, US
TIANJUN ZHOU - BELMOT MA, US

International Classification:

C07D 471/04
C07D 403/14
C07D 401/14
C07D 405/14
C07D 401/04
C07D 403/04
C07D 405/12
C07F 9/6558

Abstract:

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.

Compounds And Methods For The Treatment Of Cystic Fibrosis

View page

US Patent:

20230055237, Feb 23, 2023

Filed:

Jul 23, 2021

Appl. No.:

17/383797

Inventors:

- Canton MA, US
Christopher Oalmann - Watertown MA, US
Feng Li - Winchester MA, US
Andrew Kolodziej - Winchester MA, US
Marshall Morningstar - Framingham MA, US

International Classification:

C07D 498/20
C07D 487/20
C07D 487/10
C07D 519/00
A61K 45/06

Abstract:

The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I,and pharmaceutically acceptable slats thereof, pharmaceutical compositions comprising such compounds and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula Ito a subject in need thereof.